Insider · CIK 0001793112
Mark S Schroeder
cooofficer
Files at LH (LABCORP HOLDINGS INC.). First filing Mar 4, 2025, latest Mar 31, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $1.9M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LH: LABCORP HOLDINGS INC.
LHOct 9, 2026 · close 312.15
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 38Weak | sell 210b5-1 | LH LABCORP HOLDINGS INC. | $610k | 2,635 | -35% | +9% from low · -10% from high | |
| 45Moderate | sell 510b5-1 | LH LABCORP HOLDINGS INC. | $1.3M | 5,339 | -52% | +19% from low · -0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | LH LABCORP HOLDINGS INC. | AGrant or award Common Stock10b5-1 | +4,840 | $0.00 | $0 | 9,800 | Mar 31, 2025 |
| Mar 27, 2025 | LH LABCORP HOLDINGS INC. | FTax withholding Common Stock10b5-1 | -2,205 | $231.67 | $511k | 7,595 | Mar 31, 2025 |
| Mar 28, 2025 | LH LABCORP HOLDINGS INC. | SOpen-market sale Common Stock10b5-1 | -2,635 | $231.67 | $610k | 4,960 | Mar 31, 2025 |
| Feb 28, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Common Stock10b5-1 | +3,903 | $131.43 | $513k | 10,299 | Mar 4, 2025 |
| Feb 28, 2025 | LH LABCORP HOLDINGS INC. | SOpen-market sale Common Stock10b5-1 | -5,339 | $249.23 | $1.3M | 4,960 | Mar 4, 2025 |
| Feb 28, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Non-qualified Stock Optionsderivative10b5-1 | -3,903 | $0.00 | $0 | 0 | Mar 4, 2025 |
| Feb 11, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Common Stock | +473 | - | - | 6,530 | Feb 13, 2025 |
| Feb 11, 2025 | LH LABCORP HOLDINGS INC. | FTax withholding Common Stock | -134 | $245.14 | $33k | 6,396 | Feb 13, 2025 |
| Feb 11, 2025 | LH LABCORP HOLDINGS INC. | AGrant or award Non-qualified Stock Optionsderivative | +7,300 | $0.00 | $0 | 7,300 | Feb 13, 2025 |
| Feb 11, 2025 | LH LABCORP HOLDINGS INC. | AGrant or award Restricted Stock Unitderivative | +2,420 | $0.00 | $0 | 5,061 | Feb 13, 2025 |
| Feb 11, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Restricted Stock Unitderivative | -473 | $0.00 | $0 | 4,588 | Feb 13, 2025 |
| Feb 6, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Common Stock | +743 | - | - | 5,779 | Feb 10, 2025 |
| Feb 6, 2025 | LH LABCORP HOLDINGS INC. | FTax withholding Common Stock | -210 | $247.74 | $52k | 5,569 | Feb 10, 2025 |
| Feb 7, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Common Stock | +517 | - | - | 6,086 | Feb 10, 2025 |
| Feb 7, 2025 | LH LABCORP HOLDINGS INC. | FTax withholding Common Stock | -146 | $246.27 | $36k | 5,940 | Feb 10, 2025 |
| Feb 7, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Common Stock | +164 | - | - | 6,104 | Feb 10, 2025 |
| Feb 7, 2025 | LH LABCORP HOLDINGS INC. | FTax withholding Common Stock | -47 | $246.27 | $12k | 6,057 | Feb 10, 2025 |
| Feb 6, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Restricted Stock Unitderivative | -743 | $0.00 | $0 | 3,322 | Feb 10, 2025 |
| Feb 7, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Restricted Stock Unitderivative | -517 | $0.00 | $0 | 2,805 | Feb 10, 2025 |
| Feb 7, 2025 | LH LABCORP HOLDINGS INC. | MOption exercise Restricted Stock Unitderivative | -164 | $0.00 | $0 | 2,641 | Feb 10, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.